Concepedia

Jannik N. Andersen

JN

Statistics

Publications

32

Citations

4.6K

H-Index

28

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

The University of Texas MD Anderson Cancer Center

Cold Spring Harbor Laboratory

Novo Nordisk (Denmark)

Institute of Cancer Research

Jannik N. Andersen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and oncology.

ORCID

Publications per year

1995–2025

32

Publications

32

Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate

Annette Salmeen, Jannik N. Andersen, Michael P. Myers et al. · Nature · 2003 · 948 citations

, , +13

Cancer genomics: from discovery science to personalized medicine

Lynda Chin, Jannik N. Andersen, P. Andrew Futreal · Nature Medicine · 2011 · 675 citations

, , +14

TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B

Michael P. Myers, Jannik N. Andersen, Alan Cheng et al. · Journal of Biological Chemistry · 2001 · 467 citations · Full text

, , +14

Molecular Basis for the Dephosphorylation of the Activation Segment of the Insulin Receptor by Protein Tyrosine Phosphatase 1B

Annette Salmeen, Jannik N. Andersen, Michael P. Myers et al. · Molecular Cell · 2000 · 464 citations · Full text

, , +17

The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies

Bhavatarini Vangamudi, Thomas A. Paul, Parantu K. Shah et al. · Cancer Research · 2015 · 270 citations

, , +13

1–5 of 32